Fetal Lung Maturity Test via Centrifugation and FTIR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Respiratory Distress Syndrome (RDS) in newborns are time-consuming and unreliable, often delaying the administration of surfactant treatment due to the need for laboratory tests and reliance on heterogeneous samples, which can affect reproducibility and reliability.
Innovation Solution
A method involving centrifugation to isolate lamellar bodies from samples like gastric aspirates, followed by analysis of lecithin and sphingomyelin concentrations or the L/S ratio using FTIR spectrometry, allowing for rapid and reliable diagnosis with minimal sample volume requirements.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional laboratory tests are used to diagnose RDS, then measurement precision can be achieved, but the diagnosis becomes time-consuming and unreliable
Solution Approach 1:
The patent extracts and isolates lamellar bodies from complex biological samples (gastric aspirates, amniotic fluid, blood) through centrifugation and filtration processes. This extraction step concentrates the surfactant components (lecithin and sphingomyelin) into a purified fraction that can be rapidly analyzed, eliminating the need for time-consuming traditional laboratory tests while maintaining diagnostic accuracy
Solution Approach 2:
The patent replaces traditional mechanical laboratory testing systems with Fourier Transform Infrared Spectroscopy (FTIR). This analytical technique uses infrared light to detect the characteristic absorption patterns of phospholipid molecules, enabling rapid, objective measurement of the lecithin-sphingomyelin ratio without requiring complex mechanical processing or time-intensive laboratory procedures
2Ease of operation
If heterogeneous samples are used for RDS diagnosis, then ease of operation is improved, but measurement precision and reproducibility deteriorate
Solution Approach 1:
The patent changes the physical and chemical parameters of the sample through controlled centrifugation at specific speeds (e.g., 2000-10000 g) and filtration through membranes with defined pore sizes. These parameter changes transform heterogeneous, complex biological samples into homogeneous suspensions of isolated lamellar bodies, ensuring consistent and reproducible FTIR measurements while maintaining the ease of collecting original samples like gastric aspirates
3Ease of operation
If minimal sample volume is used, then ease of operation is improved, but measurement precision may deteriorate
Solution Approach 1:
The patent applies local quality enhancement by concentrating the surfactant components into isolated lamellar bodies through centrifugation and filtration. This process creates a highly concentrated, homogeneous sample fraction where the phospholipid molecules are densely packed, enabling accurate FTIR measurement even from minimal original sample volumes (e.g., 0.1-1 mL of gastric aspirate or amniotic fluid)
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables quick and reproducible diagnosis of RDS, facilitating timely surfactant administration and improving treatment outcomes by providing a rapid, point-of-care solution for identifying at-risk preterm infants.
Implementation Method 1
analysis of lecithin and sphingomyelin concentrations or the L/S ratio using FTIR spectrometry
Implementation Method 2
centrifugation to isolate lamellar bodies from samples like gastric aspirates
Data Source
AI summary
The present invention relates to methods for diagnosing Respiratory Distress Syndrome of newborn.